Moscow, 9 July 2013 - Pharmstandard OJSC (LSE: PHST IL, RTS: PHST RU) (“Pharmstandard” or the “Company”) would like to inform that the target of a possible acquisition, which the Company is in advanced discussions on, is BEVER PHARMACEUTICAL PTE LTD (Singapore) (“Bever Pharma”).

The Company is contemplating to acquire 100% of shares in Bever Pharma for USD630 million.

As indicated before, this acquisition will be subject to approval by the Company’s shareholders at the extraordinary shareholder meeting which will take place on 17 August 2013.

Contacts:

Irina Bakhturina
Investor Relations
Pharmstandard OJSC
Tel.: +7 (495) 970-0030 Ext.2824
E-mail: ir@pharmstd.ru
www.pharmstd.com